+

Shinoda et al., 1987 - Google Patents

Inhibitory effect of capsular antigen of Vibrio vulnificus on bactericidal activity of human serum

Shinoda et al., 1987

View PDF @Full View
Document ID
15100388459809299458
Author
Shinoda S
Kobayashi M
Yamada H
Yoshida S
Ogawa M
Mizuguchi Y
Publication year
Publication venue
Microbiology and immunology

External Links

Snippet

on Bactericidal Activity of Human Serum Vibrio vulnificus, a slightly halophilic marine bacterium, has been recently recognized Page 1 Microbiol. Immunol. Vol. 31 (5), 393-401, 1987 Inhibitory Effect of Capsular Antigen of •ôNH•ôVibrio vulnificus•ôNS•ô on Bactericidal Activity of Human …
Continue reading at www.jstage.jst.go.jp (PDF) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/569Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56916Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Micro-organisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Micro-organisms or materials therefrom
    • A61K35/74Bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
    • C12Q1/04Determining presence or kind of micro-organism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Similar Documents

Publication Publication Date Title
Stoenner et al. Antigenic variation of Borrelia hermsii.
Cavanaugh et al. The role of multiplication of Pasteurella pestis in mononuclear phagocytes in the pathogenesis of flea-borne plague
Williams et al. Immunological and biological characterization of Coxiella burnetii, phases I and II, separated from host components
Eisenstein Evidence for O antigens as the antigenic determinants in" ribosomal" vaccines prepared from Salmonella
Gemski Jr et al. Virulence of Shigella flexneri hybrids expressing Escherichia coli somatic antigens
Vaara et al. An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action.
Shinoda et al. Inhibitory effect of capsular antigen of Vibrio vulnificus on bactericidal activity of human serum
Thomas et al. Studies on primary atypical pneumonia. II. Observations concerning the relationship of a non-hemolytic streptococcus to the disease
Namioka Chapter X Pasteurella multocida---Biochemical Characteristics and Serotypes
Sakulramrung et al. Cross-reactive immunoprotective antibodies to Escherichia coli 0111 rough mutant J5
Kreger et al. Protection of mice against Vibrio vulnificus disease by vaccination with surface antigen preparations and anti-surface antigen antisera
Guirguis et al. Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies.
Mulholland et al. Quantitative studies of febrile tolerance and levels of specific antibody evoked by bacterial endotoxin
Young et al. Agar-gel precipitating antibody in Pseudomonas aeruginosa infections
Lancefield Loss of the properties of hemolysin and pigment formation without change in immunological specificity in a strain of Streptococcus haemolyticus
Bokkenheuser Vibrio fetus infection in man: a serological test
Beachey et al. Type-specific inhibition of preopsonization versus immunoprecipitation by streptococcal M proteins
Domingue et al. Opsonizing and bactericidal activity of antibodies against common antigen of Enterobacteriaceae
Wiley et al. The ability of group A streptococci killed by heat or mercury arc irradiation to resist ingestion by phagocytes
Gilsdorf et al. Susceptibility of phenotypic variants of Haemophilus influenzae type b to serum bactericidal activity: relation to surface lipopolysaccharide
Pitt et al. 3 Serological Typing of Serratia marcescens
Zweerink et al. X-linked immunodeficient mice as a model for testing the protective efficacy of monoclonal antibodies against Pseudomonas aeruginosa
Neter et al. Study on antibodies against enteric pathogens in human gamma globulin
Fierer et al. Release of 51Cr-endotoxin from bacteria as an assay of serum bactericidal activity
Scales et al. Development and passive transfer of immunity to gonococcal infection in guinea pigs
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载